A Standardized Approach to Treatment Over Objection in Patients Lacking Decision-Making Capacity Secondary to Neurologic Disease
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received January 24, 2022
- Accepted May 12, 2022
- First Published September 9, 2022.
Article Versions
- Previous version (September 9, 2022 - 12:45).
- You are viewing the most recent version of this article.
Author Disclosures
- Jeremy Ader, MD, MBA,
- Marc L. Otten, MD,
- Adam Critchfield, MD and
- Kenneth M. Prager, MD
- Jeremy Ader, MD, MBA,
None
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
- Marc L. Otten, MD,
None
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
None
NONE
NONE
NONE
NONE
Abbott Laboratories, Alphabet Inc., Becton Dickinson, <br>Biogen, Bristol-Myers Squibb, Gilead, Johnson and Johnson, <br>Merck, Moderna, Organon, Pfizer, Regeneron
Consultant for a hospital system for clinical care, <br>unrelated to this study.
- Adam Critchfield, MD and
None
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
- Kenneth M. Prager, MD
None
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
None
NONE
NONE
NONE
NONE
NONE
Ethics consultant for a legal firm regarding a malpractice<br>case
- Department of Neurology (JA), Columbia University Irving Medical Center; Department of Neurosurgery (MLO), Columbia University Irving Medical Center; Department of Consultation-Liaison Psychiatry (AC), Columbia University Irving Medical Center; and Department of Medicine (KMP), Columbia University Irving Medical Center.
- Correspondence
Dr. Ader ja3296{at}cumc.columbia.edu
Article usage
The Nerve!: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Ann Yeh and Dr. Daniela Castillo Villagrán
► Watch
Related Articles
- No related articles found.